Published in Cell Reports · View the paper (DOI)
A study found that supercentenarians, people who live to 110 and beyond, have a higher proportion of cancer-killing immune cells called CD4 CTLs. This expansion may help the immune system adapt to age-related challenges, contributing to exceptional longevity.
Coverage from 2 institutions